ATE223406T1 - 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression - Google Patents

1,4-disubstitutierte cyclohexanderivate zur behandlung von depression

Info

Publication number
ATE223406T1
ATE223406T1 AT00903156T AT00903156T ATE223406T1 AT E223406 T1 ATE223406 T1 AT E223406T1 AT 00903156 T AT00903156 T AT 00903156T AT 00903156 T AT00903156 T AT 00903156T AT E223406 T1 ATE223406 T1 AT E223406T1
Authority
AT
Austria
Prior art keywords
hydrogen
treatment
depression
halogen
alkyl
Prior art date
Application number
AT00903156T
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Reinhardt Bernhard Baudy
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE223406T1 publication Critical patent/ATE223406T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00903156T 1999-01-07 2000-01-06 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression ATE223406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22655299A 1999-01-07 1999-01-07
PCT/US2000/000348 WO2000040579A1 (en) 1999-01-07 2000-01-06 New 1,4-disubstituted cyclohexane derivatives for the treatment of depression

Publications (1)

Publication Number Publication Date
ATE223406T1 true ATE223406T1 (de) 2002-09-15

Family

ID=22849378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903156T ATE223406T1 (de) 1999-01-07 2000-01-06 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression

Country Status (11)

Country Link
EP (1) EP1140919B1 (de)
JP (1) JP2002534426A (de)
CN (1) CN1335844A (de)
AT (1) ATE223406T1 (de)
AU (1) AU2494400A (de)
CA (1) CA2355361A1 (de)
DE (1) DE60000405T2 (de)
DK (1) DK1140919T3 (de)
ES (1) ES2182775T3 (de)
PT (1) PT1140919E (de)
WO (1) WO2000040579A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004531506A (ja) 2001-03-29 2004-10-14 ブリストル−マイヤーズ スクイブ カンパニー 選択的なセロトニン再取り込みインヒビターとしてのシクロプロピルインドール誘導体
CN100391974C (zh) * 2006-01-09 2008-06-04 浙江理工大学 一种重组胶原蛋白及其合成和表达纯化方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907974A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Indolderivate
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5322851A (en) * 1990-07-02 1994-06-21 H. Lundbeck A/S Indole derivatives
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
GB9300194D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5-取代-3-(1,2,3,6-四氢吡啶-4-基)-和3-(哌啶-4-基)-1h-吲哚:新型5-ht1f激动剂
TW530054B (en) * 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds

Also Published As

Publication number Publication date
CN1335844A (zh) 2002-02-13
ES2182775T3 (es) 2003-03-16
AU2494400A (en) 2000-07-24
DE60000405D1 (de) 2002-10-10
DK1140919T3 (da) 2002-12-30
CA2355361A1 (en) 2000-07-13
EP1140919B1 (de) 2002-09-04
DE60000405T2 (de) 2003-08-07
EP1140919A1 (de) 2001-10-10
WO2000040579A1 (en) 2000-07-13
JP2002534426A (ja) 2002-10-15
PT1140919E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
DK1260512T3 (da) Hidtil ukendte, cykliske amidderivater
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
DK1277736T3 (da) Hidtil ukendte bicykliske forbindelser
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
GB9801690D0 (en) Therapeutic agents
AU2003254852A8 (en) Fused heterocyclic compounds as peptidase inhibitors
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
TR199900096T2 (xx) Bradykinin B2 antagonistleri olarak elveri�li N-benzensulfonil-L-prolin t�revleri.
ATE239741T1 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
NO995289D0 (no) Benzimidazol-derivater
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE283840T1 (de) Chondrogonese promotoren und indolin-2-on derivate
ATE223406T1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
DE69902766D1 (de) N-aryloxyethylaminderivate zur behandlung der depression
SE9704770D0 (sv) New use
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ES2193047T3 (es) (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
DE69916577D1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE220665T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee